Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system

Nucleic Acids Res. 2017 May 19;45(9):5198-5207. doi: 10.1093/nar/gkx130.

Abstract

Genome editing research of human ES/iPS cells has been accelerated by clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9) and transcription activator-like effector nucleases (TALEN) technologies. However, the efficiency of biallelic genetic engineering in transcriptionally inactive genes is still low, unlike that in transcriptionally active genes. To enhance the biallelic homologous recombination efficiency in human ES/iPS cells, we performed screenings of accessorial genes and compounds. We found that RAD51 overexpression and valproic acid treatment enhanced biallelic-targeting efficiency in human ES/iPS cells regardless of the transcriptional activity of the targeted locus. Importantly, RAD51 overexpression and valproic acid treatment synergistically increased the biallelic homologous recombination efficiency. Our findings would facilitate genome editing study using human ES/iPS cells.

MeSH terms

  • Alleles*
  • CRISPR-Cas Systems / genetics*
  • Gene Editing*
  • Genome, Human*
  • Homologous Recombination / drug effects
  • Homozygote
  • Human Embryonic Stem Cells / cytology
  • Human Embryonic Stem Cells / drug effects
  • Human Embryonic Stem Cells / metabolism*
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / drug effects
  • Induced Pluripotent Stem Cells / metabolism*
  • Rad51 Recombinase / genetics
  • Transcription Activator-Like Effector Nucleases / metabolism*
  • Transcription, Genetic / drug effects
  • Valproic Acid / pharmacology

Substances

  • Valproic Acid
  • Rad51 Recombinase
  • Transcription Activator-Like Effector Nucleases